INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Inspire Medical Systems, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$70.15+1.36 (+1.98%)

Close on Oct 19, 2026

Market cap: $2.03B
P/E (TTM): 15.2
Dividend yield: –

Inspire Medical Systems, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31
Cash & Equivalents	128	99	105	113	107	54	150	148	188	175	186	330	467	442	442	418	187	203	214	210	177	182	191	179	211	76	23	48	51	102	97	26	122	11	8.96	15	23	27	6.69
Short-Term Investments	193	185	203	210	194	315	295	263	252	266	275	134	0	9.93	9.82	9.74	9.75	–	0	0	31	44	44	56	31	60	127	104	107	75	91	94	2.11	6.76	7.19	–	–	–	–
Cash & Short-Term Investments	321	284	308	323	301	369	446	411	440	441	460	464	467	452	451	428	196	203	214	210	208	226	234	235	243	136	149	152	159	177	188	120	124	18	16	15	23	27	6.69
Receivables	103	105	120	108	138	93	93	90	80	72	90	71	64	60	61	48	40	35	34	27	25	22	25	21	10	11	13	11	9.47	7.04	6.67	5.41	4.49	3.46	3.86	–	–	–	–
Inventory	170	166	145	142	122	100	80	67	59	49	34	26	21	16	12	15	22	22	17	16	13	11	8.48	8.97	9.97	7.25	5.83	4.68	3.56	3.11	2.67	3.08	3.55	3.39	3.67	–	–	–	–
Prepaid Expenses & Other	14	12	10	14	13	10	12	14	29	9.55	9.60	7.80	8.69	6.09	5.51	4.35	4.57	2.44	2.66	3.05	3.45	1.61	1.97	2.22	4.35	1.43	2.21	3.20	5.60	1.39	1.73	1.04	1.03	2.19	0.43	–	–	–	–
Total Current Assets	609	567	584	586	573	572	631	583	607	572	594	570	560	534	530	496	263	262	269	255	249	261	270	267	267	155	171	170	177	189	199	130	133	27	24	–	–	–	–
Property, Plant & Equipment	104	101	98	92	85	77	72	67	62	52	40	32	25	21	17	14	11	9.33	8.49	7.92	7.07	6.79	5.31	4.31	3.31	3.11	3.05	2.76	1.83	0.97	0.80	0.77	0.87	0.91	0.99	–	–	–	–
Gross Property, Plant & Equipment	–	–	124	115	105	94	86	79	71	60	47	39	31	26	22	18	15	13	12	11	9.44	8.86	7.16	5.90	4.69	4.31	4.05	3.61	2.55	1.59	1.60	1.55	1.85	1.79	1.80	–	–	–	–
Accumulated Depreciation	–	–	-26	-24	-20	-17	-14	-11	-9.49	-8.11	-7.27	-6.94	-6.16	-5.50	-4.91	-4.34	-3.83	-3.41	-3.05	-2.71	-2.37	-2.07	-1.85	-1.59	-1.38	-1.19	-1.01	-0.85	-0.72	-0.61	-0.80	-0.79	-0.98	-0.88	-0.81	–	–	–	–
Long-Term Investments	94	116	96	88	110	45	71	113	26	28	9.14	2.96	–	0	0	0	0	9.80	9.94	9.98	9.98	0	0	0	0	6.14	6.28	9.63	6.12	0	0	0	–	–	0	–	–	–	–
Operating Lease Right-of-Use Assets	23	23	24	24	25	25	23	22	22	22	23	23	21	6.61	6.88	7.14	7.40	7.66	7.92	5.30	5.47	5.63	5.81	0.17	0.42	0.67	0.92	–	–	–	0	–	–	–	–	–	–	–	–
Deferred Tax Assets	78	88	89	–	–	–	0.01	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	18	17	17	17	9.38	12	11	11	11	11	11	12	12	11	11	11	10	0.45	0.20	0.20	0.20	–	0.20	–	–	–	0.38	–	–	–	0	–	–	–	–	–	–	–	–
Total Assets	926	911	907	808	802	731	808	796	728	686	677	639	618	572	565	528	292	290	295	279	272	273	281	272	271	166	181	183	186	190	200	131	134	28	25	–	–	–	–
Accrued Expenses	44	48	59	52	40	34	50	39	32	28	39	30	27	23	34	29	19	14	20	17	13	10	14	11	7.94	7.90	12	7.87	5.98	4.62	7.73	4.96	4.20	3.14	4.15	–	–	–	–
Current Portion of Leases	–	–	2.16	2.27	2.15	2.04	1.75	0.11	–	–	0	0	1.32	1.37	1.34	1.25	1.07	0.67	0.31	0.03	–	–	0	0.09	0.34	0.59	0.83	–	–	–	0	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	2.45	1.00	1.10	0.91	1.61	1.84	–	–	0.58	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	71	89	96	111	93	63	89	74	66	72	78	70	67	60	61	49	47	43	41	34	24	19	21	18	13	14	17	13	8.66	7.83	11	7.60	9.34	7.92	7.15	–	–	–	–
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	9.80	13	16	19	22	25	25	25	25	25	25	24	24	24	25	25	22	24	16	–	–	–	–
Long-Term Leases	29	30	30	30	31	31	30	25	25	25	25	25	22	7.19	7.54	7.88	8.22	8.55	8.80	6.08	6.03	5.96	5.89	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	29	30	32	33	33	34	32	25	25	25	25	25	23	8.55	8.87	9.13	9.30	9.23	9.11	6.11	6.03	5.96	5.89	0.09	0.34	0.59	0.83	–	–	–	0	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.14	0.07	0.10	0.11	0.11	0.11	0.15	0.15	0.15	0.15	1.35	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.13	0.12	0.11	0.10	0.09	0.07	0.04	0.04	0.04	–	–	–	0	–	–	–	–	–	–	–	–
Total Liabilities	100	119	126	141	124	95	119	100	90	97	104	95	89	67	69	57	65	65	66	59	52	50	51	43	38	38	41	37	33	32	36	32	31	33	24	–	–	–	–
Total Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	9.80	13	16	19	22	25	25	25	25	25	25	24	24	24	25	25	22	24	16	–	–	–	–
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–	0	0	–	119	119	–	–	–	–
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.00	0.00	–	–	–	–
Additional Paid-In Capital	984	950	927	948	970	924	981	1,022	984	944	917	904	881	844	820	798	538	521	508	497	487	477	467	459	453	323	320	317	315	313	311	240	240	7.55	7.31	–	–	–	–
Retained Earnings	-157	-158	-146	-283	-293	-289	-292	-327	-346	-355	-345	-360	-352	-340	-324	-327	-311	-296	-279	-277	-267	-254	-237	-230	-219	-196	-180	-171	-163	-155	-147	-142	-137	-132	-125	–	–	–	–
Comprehensive Income & Other	-0.65	-0.35	0.46	0.64	0.40	0.23	0.54	1.70	-0.12	0.12	0.80	0.04	0.10	0.03	-0.09	-0.36	-0.20	-0.20	-0.06	-0.01	-0.01	0.01	0.03	0.07	0.15	0.30	0.10	0.09	0.05	0.02	-0.05	-0.03	0	–	0	–	–	–	–
Shareholders' Equity	826	792	781	666	678	636	690	697	638	589	573	544	529	505	496	470	227	225	229	220	220	223	230	229	234	127	140	146	152	157	164	98	103	-4.94	1.33	–	–	–	-6.61
Total Equity	826	792	781	666	678	636	690	697	638	589	573	544	529	505	496	470	227	225	229	220	220	223	230	229	234	127	140	146	152	157	164	98	103	-4.93	1.33	–	–	–	-6.61
Total Liabilities & Equity	926	911	907	808	802	731	808	796	728	686	677	639	618	572	565	528	292	290	295	279	272	273	281	272	271	166	181	183	186	190	200	131	134	28	25	–	–	–	–
Shares Outstanding(shares)	29	29	29	29	30	29	30	30	30	30	30	29	29	29	29	29	28	28	27	27	27	27	27	27	27	24	24	24	24	24	23	21	21	1.38	1.27	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 86.1%
Operating margin: 6.0%
Net margin: 15.0%
Return on equity, FY2025: 19.8%

Financial strength

Current ratio: 8.55
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 179.5%

Valuation

P/E ratio: 15.2
Price to sales: 2.26
Price to book: 2.46
Dividend yield: –